"The Company plans for a Phase 2 proof of concept trial for ulcerative proctitis to begin in March 2016."
Let's just see. Hopefully the company isn't diverting attention from B-ABSSSI or K to start that trial.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
-
-
-
-
-
-
-